Abstract: The present disclosure provides a safe method for opioid abuse deterrence, anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects. When the novel pain medication contains doxapram and an opioid, it can also be used as an opioid abuse deterrent.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: The present disclosure provides a safe method for anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant. In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects.

Abstract: A tire testing apparatus includes a tire supporting structure, a force applying device, a force measuring device and a controller. The tire supporting structure is configured to retain a tire. The force applying device is attached to the tire supporting structure and is configured to selectively apply a static force to the tire with the tire retained by the tire supporting structure. The force measuring device is attached to the tire supporting structure and is configured to measure the static force applied to the tire applied by the force applying device. The controller is electronically connected to the force applying device and the force measuring device. The controller is configured to receive force measurements from the force measuring device and selectively operate the force applying device to apply a predetermined level of static force to the tire for a predetermined period of time.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: A tire testing apparatus includes a tire supporting structure, a force applying device, a force measuring device and a controller. The tire supporting structure is configured to retain a tire. The force applying device is attached to the tire supporting structure and is configured to selectively apply a static force to the tire with the tire retained by the tire supporting structure. The force measuring device is attached to the tire supporting structure and is configured to measure the static force applied to the tire applied by the force applying device. The controller is electronically connected to the force applying device and the force measuring device. The controller is configured to receive force measurements from the force measuring device and selectively operate the force applying device to apply a predetermined level of static force to the tire for a predetermined period of time.

Abstract: A pill dispensing system and associated methods are configured for managing the distribution of pills to a patient. In at least one embodiment, an at least one tamper-proof pill storage container provides an at least one pill magazine positioned within a housing of the pill storage container and configured for storing and selectively dispensing a plurality of pills through a pill outlet provided by the housing. A patient application, residing in memory on an at least one patient device under the control of the patient, is in selective communication with the at least one pill storage container. An at least one monitoring device is in selective communication with the patient application, the at least one monitoring device configured for assisting the patient application with monitoring an at least one vital of the patient.

Abstract: The present disclosure provides a safe method for anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant. In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects.

Abstract: A system for operating a tamper proof storage container for pills, where the storage container has a shutter mechanism that is locked by the combination of a biometric fingerprint lock and digital combination lock. The shutter is opened only upon signal from a personal or remote computer, which allows operation of the fingerprint biometric lock and the digital combination lock. The shutter will dispense only the number of pills prescribed.

Abstract: The present disclosure provides a safe method for anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant. In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects.

Abstract: A frequency synthesizer with microcode control that allows one or more programmable circuits of a frequency synthesizer system to be programmed using a plurality of microcode instructions. A method includes, setting a frequency synthesizer system to operate in a microcode mode, programming the frequency synthesizer system for microcode execution of a plurality of microcode instructions and executing the plurality of microcode instructions at the frequency synthesizer system to control one or more behaviors of one or more programmable circuits of the frequency synthesizer system.

Abstract: The present disclosure provides a safe method for anesthesia or the treatment of pain by safely administering an amount of active agent to a patient while reducing the incidence or severity of suppressed respiration. The present disclosure provides a pharmaceutical composition comprising a therapeutic agent and a chemoreceptor respiratory stimulant. In one aspect, the compositions oppose effects of respiratory suppressants by combining a chemoreceptor respiratory stimulant with an opioid receptor agonist or other respiratory-depressing drug. The combination of the two chemical agents, that is, the therapeutic agent and the respiratory stimulant, may be herein described as the “drugs.” The present compositions may be used to treat acute and chronic pain, sleep apnea, and other conditions, leaving only non-lethal side effects.

Abstract: Techniques for adaptive trace logging include, in one embodiment, obtaining input data on trace logging behavior and computing resources used by trace logging. Based on the obtained input data, an adaptive trace logging module automatically takes action at runtime to reduce the amount of computing resources consumed by tracing logging. For example, the action taken may include decreasing a trace logging level of an executing software program to reduce the number of trace logging messages added to a trace log. In another embodiment, the techniques include detecting a condition of an executing software program that warrants a change to a trace logging level of the executing program. The adaptive trace logging module automatically changes the trace logging level of the executing program as-needed for the detected condition. For example, the adaptive trace logging module may increase the trace logging level of an executing program upon detecting a deadlock or other abnormal condition of the executing program.

Abstract: The present invention provides a method and a programmable timing device that includes a timing device circuit for generating at least one timing signal, a static random access memory (SRAM) coupled to the timing device circuit, a read only memory (ROM) having a first timing device configuration stored therein, a one time programmable non volatile memory (OTP NVM) for storing a second timing device configuration and selection logic. The selection logic includes an output coupled to the SRAM, a first input coupled to the ROM and a second input coupled to the OTP NVM. The selection logic is operable to receive input indicating whether SRAM is to be loaded from the ROM or the OTP NVM, and operable to load either the first timing device configuration from the ROM or the second timing device configuration from the OTP NVM based on the input.

Abstract: A programmable low power driver permits an output impedance of the driver to be programmed. Programmability permits the driver output impedance to match an impedance of a transmission line that is connected thereto. The low power driver includes a first driver output and a plurality of driver legs. The programmable low power driver is configured to electrically couple one or more driver legs of the plurality of driver legs to the first driver output to establish an output impedance for the driver.

Abstract: An output driver is provided that adapts an output impedance of the output driver to the voltage level of a power supply, thereby providing a constant output impedance over a range of different operating voltages. The output driver includes a plurality of individual driver circuits, each one of the plurality of individual driver circuits configured to provide a plurality of predetermined output impedances in response to a plurality of power supply voltage level inputs and a decoder.

Abstract: An low voltage differential signaling (LVDS) driver is provide having an output voltage amplitude regulator for regulating an output voltage amplitude of the LVDS driver by receiving a differential output signal from a switched-polarity current generator of the LVDS driver at an output voltage amplitude regulator of the LVDS driver, detecting an output voltage amplitude of the differential output signal, comparing the output voltage amplitude to a reference voltage at the output voltage amplitude regulator and regulating a steering current of the LVDS driver based upon the comparison between the output voltage amplitude and the reference voltage to regulate an amplitude of the differential output signal at one or more loads of the LVDS driver.